Hepatocyte growth factor‐modified adipose‐derived mesenchymal stem cells inhibit human hypertrophic scar fibroblast activation
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Tianli Zhang. Beteiligte Einrichtung: Medical College Wuhan University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Cicatrix, Hypertrophic, Hepatocyte Growth Factor, Mesenchymal Stem Cells, Fibroblasts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Nucleoside‐modified messenger RNA (modRNA) holds the potential for facilitating genetic enhancement of stem cells. In this study, modRNA encoding hepatocyte growth factor (modHGF) was used to chemically modify adipose‐derived mesenchymal stem cells (ADSCs) and the effect of modified ADSCs on the activation of hypertrophic scar fibroblasts (HSFs) was evaluated.
Methods
CCK‐8, wound healing, and transwell assays were utilized to evaluate the viability and migratory potential of modHGF‐engineered ADSCs and their effect on HSF activation. Reverse transcription‐polymerase chain reaction, western blot, and immunofluorescence staining were performed to detect the expression of collagen‐I (Col I), collagen‐III (Col III), alpha‐smooth muscle actin (α‐SMA), matrix metallopeptidase 1 (MMP‐1), and MMP‐3.
Results
Transfection of ADSCs with modHGF (HGF‐ADSC) resulted in enhanced production of HGF. Meanwhile, modHGF modification enhanced the viability and migration of ADSCs. Notably, culture media from HGF‐ADSCs exhibited a more potent inhibitory effect on the proliferation and migration of HSFs. In addition, culture media from HGF‐ADSCs inhibited extracellular matrix synthesis of HSFs, as evidenced by reduced expression levels of Col I, Col III, and α‐SMA, while increasing expression of MMP‐1 and MMP‐3. Conversely, neutralization experiments confirmed that these effects could be effectively alleviated by blocking HGF activity. Conclusion modHGF modification optimizes the inhibitory effect of ADSCs on HSF activation, which provides a promising alternative for preventing and treating hyperplastic scars.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical College Wuhan University of Science and Technology, Wuhan, Hubei, China.
Zitieren
APA
Zhang, T. (2024). Hepatocyte growth factor‐modified adipose‐derived mesenchymal stem cells inhibit human hypertrophic scar fibroblast activation. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16509
Vancouver
Zhang T. Hepatocyte growth factor‐modified adipose‐derived mesenchymal stem cells inhibit human hypertrophic scar fibroblast activation. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16509
BibTeX
@article{Zhang2024,
author = {Zhang, Tianli},
title = {Hepatocyte growth factor‐modified adipose‐derived mesenchymal stem cells inhibit human hypertrophic scar fibroblast activation},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16509}
}
EUVIMED